Abbvie Inc
NYSE:ABBV
Abbvie Inc
NYSE:ABBV
Price:
162.35 USD
-2.95%
Market Closed
Updated:
Apr 26, 2024
Abbvie Inc
Net Issuance of Common Stock
|
Abbvie Inc
Net Issuance of Common Stock Peer Comparison
Comparables:
GILD
AMGN
MRNA
VRTX
REGN
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbvie Inc
NYSE:ABBV
|
Net Issuance of Common Stock
-$1.8B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Issuance of Common Stock
-$768m
|
CAGR 3-Years
17%
|
CAGR 5-Years
22%
|
CAGR 10-Years
-11%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Issuance of Common Stock
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Moderna Inc
NASDAQ:MRNA
|
Net Issuance of Common Stock
-$1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Issuance of Common Stock
-$293m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Issuance of Common Stock
-$1.1B
|
CAGR 3-Years
31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbvie Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
-1.8B
USD
-1.8B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Net Issuance of Common Stock amounts to -1.8B USD.
What is Abbvie Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
32%
32%
Over the last year, the Net Issuance of Common Stock growth was -46%. The average annual Net Issuance of Common Stock growth rates for Abbvie Inc have been -33% over the past three years , 32% over the past five years .
You don't have any saved screeners yet
